Cargando…

Examination of the Novel Sigma-1 Receptor Antagonist, SI 1/28, for Antinociceptive and Anti-allodynic Efficacy against Multiple Types of Nociception with Fewer Liabilities of Use

Neuropathic pain is a significant problem with few effective treatments lacking adverse effects. The sigma-1 receptor (S1R) is a potential therapeutic target for neuropathic pain, as antagonists for this receptor effectively ameliorate pain in both preclinical and clinical studies. The current resea...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wilson, Lisa L., Eans, Shainnel O., Ramadan-Siraj, Insitar, Modica, Maria N., Romeo, Giuseppe, Intagliata, Sebastiano, McLaughlin, Jay P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8775934/ https://www.ncbi.nlm.nih.gov/pubmed/35054797 http://dx.doi.org/10.3390/ijms23020615

Ejemplares similares

Development of New Benzylpiperazine Derivatives as σ(1) Receptor Ligands with in Vivo Antinociceptive and Anti-Allodynic Effects
por: Romeo, Giuseppe, et al.
Publicado: (2021)

Identification and Pharmacological Characterization of a Low-Liability Antinociceptive Bifunctional MOR/DOR Cyclic Peptide
por: Li, Yangmei, et al.
Publicado: (2023)

Characterization of Sigma 1 Receptor Antagonist CM-304 and Its Analog, AZ-66: Novel Therapeutics Against Allodynia and Induced Pain
por: Cirino, Thomas J., et al.
Publicado: (2019)

Characterization of CM-398, a Novel Selective Sigma-2 Receptor Ligand, as a Potential Therapeutic for Neuropathic Pain
por: Wilson, Lisa L., et al.
Publicado: (2022)

Selective κ receptor partial agonist HS666 produces potent antinociception without inducing aversion after i.c.v. administration in mice
por: Spetea, Mariana, et al.
Publicado: (2017)

Tryptophan Substitution in CJ-15,208 (cyclo[Phe-D-Pro-Phe-Trp]) Introduces δ-Opioid Receptor Antagonism, Preventing Antinociceptive Tolerance and Stress-Induced Reinstatement of Extinguished Cocaine-Conditioned Place Preference
por: Scherrer, Kristen H., et al.
Publicado: (2023)

Direct Phenotypic Screening in Mice: Identification of Individual, Novel Antinociceptive Compounds from a Library of 734 821 Pyrrolidine Bis-piperazines
por: Houghten, Richard A., et al.
Publicado: (2015)

Recent Advances in the Development of Sigma Receptor Ligands as Cytotoxic Agents: A Medicinal Chemistry Perspective
por: Fallica, Antonino N., et al.
Publicado: (2021)

Sulforaphane Inhibited the Nociceptive Responses, Anxiety- and Depressive-Like Behaviors Associated With Neuropathic Pain and Improved the Anti-allodynic Effects of Morphine in Mice
por: Ferreira-Chamorro, Pablo, et al.
Publicado: (2018)

Anti-Allodynic Effects of Levodopa in Neuropathic Rats
por: Park, Hue Jung, et al.
Publicado: (2013)

Ion Channels Involved in Substance P-Mediated Nociception and Antinociception
por: Chang, Chu-Ting, et al.
Publicado: (2019)

Lysionotin exerts antinociceptive effects in various models of nociception induction
por: Alqudah, Abdelrahim, et al.
Publicado: (2023)

Helping Haiti’s transportation issues: Increasing Haiti’s medical liabilities
por: McLaughlin, Nancy, et al.
Publicado: (2013)

Sigma-1 receptors and progesterone metabolizing enzymes in nociceptive sensory neurons of the female rat trigeminal ganglia: A neural substrate for the antinociceptive actions of progesterone
por: Hornung, Rebecca S, et al.
Publicado: (2022)

Solid-Phase Synthesis of the Bicyclic Peptide OL-CTOP Containing Two Disulfide Bridges, and an Assessment of Its In Vivo μ-Opioid Receptor Antagonism after Nasal Administration
por: Rayala, Ramanjaneyulu, et al.
Publicado: (2023)

The Sigma 2 receptor promotes and the Sigma 1 receptor inhibits mu-opioid receptor-mediated antinociception
por: Sánchez-Blázquez, Pilar, et al.
Publicado: (2020)

Nonpeptide Small Molecule Agonist and Antagonist Original Leads for Neuropeptide FF1 and FF2 Receptors
por: Journigan, V. Blair, et al.
Publicado: (2014)

Mutual Prodrugs of 5‐Fluorouracil: From a Classic Chemotherapeutic Agent to Novel Potential Anticancer Drugs
por: Ciaffaglione, Valeria, et al.
Publicado: (2021)

Antinociceptive Effects of Transcytosed Botulinum Neurotoxin Type A on Trigeminal Nociception in Rats
por: Kim, Hye-Jin, et al.
Publicado: (2015)

Antinociceptive and anti-inflammatory activities of butein in different nociceptive and inflammatory mice models
por: Gao, Li, et al.
Publicado: (2021)

Bis-Cyclic Guanidine Heterocyclic Peptidomimetics as Opioid Ligands with Mixed μ-, κ- and δ-Opioid Receptor Interactions: A Potential Approach to Novel Analgesics
por: McLaughlin, Jay P., et al.
Publicado: (2022)

A stable isotope dilution tandem mass spectrometry method of major kavalactones and its applications
por: Wang, Yi, et al.
Publicado: (2018)

Phenylalanine Stereoisomers of CJ-15,208 and [d-Trp]CJ-15,208 Exhibit Distinctly Different Opioid Activity Profiles
por: Brice-Tutt, Ariana C., et al.
Publicado: (2020)

Guiding opioid-free intravenous antinociception with the Analgesia Nociception Index: a case report
por: Coeckelenbergh, Sean, et al.
Publicado: (2020)

Combination of Heme Oxygenase-1 Inhibition and Sigma Receptor Modulation for Anticancer Activity
por: Romeo, Giuseppe, et al.
Publicado: (2021)

PM287. Mixtures of opioid receptor agonists and cannabinoid receptor agonists: enhanced antinociception without abuse liability
por: France, Charles P, et al.
Publicado: (2016)

The spinal antinociceptive effects of cholinergic drugs in rats: receptor subtype specificity in different nociceptive tests
por: Lograsso, Michael, et al.
Publicado: (2002)

Antinociceptive Effects of Spinal Manipulative Therapy on Nociceptive Behavior of Adult Rats during the Formalin Test
por: Onifer, Stephen M., et al.
Publicado: (2015)

Antinociceptive Effects of Prim-O-Glucosylcimifugin in Inflammatory Nociception via Reducing Spinal COX-2
por: Wu, Liu-Qing, et al.
Publicado: (2016)

O067. Osmophobia in allodynic migraine: role of frequency of attacks and headache duration
por: Lovati, Carlo, et al.
Publicado: (2015)

Purple Corn Extract as Anti-allodynic Treatment for Trigeminal Pain: Role of Microglia
por: Magni, Giulia, et al.
Publicado: (2018)

Strategies to Improve Resveratrol Systemic and Topical Bioavailability: An Update
por: Intagliata, Sebastiano, et al.
Publicado: (2019)

The Antinociceptive Responses of MTDZ to Paclitaxel−Induced Peripheral Neuropathy and Acute Nociception in Mice: Behavioral, Pharmacological, and Biochemical Approaches
por: da Motta, Ketlyn P., et al.
Publicado: (2023)

Trigeminal injury causes kappa opioid-dependent allodynic, glial and immune cell responses in mice
por: Aita, Megumi, et al.
Publicado: (2010)

Anti-Allodynic Effects of Polydeoxyribonucleotide in an Animal Model of Neuropathic Pain and Complex Regional Pain Syndrome
por: Lee, Sung Hyun, et al.
Publicado: (2020)

Anti-allodynic and promotive effect on inhibitory synaptic transmission of riluzole in rat spinal dorsal horn
por: Taiji, Ryo, et al.
Publicado: (2021)

Mood After CPAP: Fewer Patients With Depression, but not Fewer With Anxiety
por: Marrone, Oreste
Publicado: (2019)

Sigma-1 Receptor Agonism Promotes Mechanical Allodynia After Priming the Nociceptive System with Capsaicin
por: Entrena, J. M., et al.
Publicado: (2016)

Antinociceptive Profile of Levo-tetrahydropalmatine in Acute and Chronic Pain Mice Models: Role of spinal sigma-1 receptor
por: Kang, Dong-Wook, et al.
Publicado: (2016)

Anti-allodynic Efficacy of NMDA Antagonist Peptide and Noradrenaline Alone and in Combination in Rodent Neuropathic Pain Model
por: Nasirinezhad, Farinaz, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_nk1elq42kojuhkistj2nt79edv